back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-03-28 17:57 Tx date 2025-03-04 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$100,000
+16,000 vol $6.25 each |
20,609 | |
| Filed 2025-03-28 17:56 Tx date 2025-03-04 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-100,000
-16,000 vol $6.25 each |
30,000 | |
| Filed 2025-02-03 17:27 Tx date 2025-02-03 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
99 - Correction of information
|
-188,940 vol |
4,609 | |
| Filed 2024-11-08 07:51 Tx date 2024-11-04 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,099,998
+188,940 vol $21.70 each |
193,549 | |
| Filed 2024-11-07 11:07 Tx date 2024-11-04 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$100,015
+4,609 vol $21.70 each |
4,609 | |
| Filed 2024-10-29 20:23 Tx date 2024-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$8,250
+5,000 vol $1.65 each |
46,000 | |
| Filed 2024-10-29 20:22 Tx date 2024-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$9,200
+5,000 vol $1.84 each |
41,000 | |
| Filed 2024-10-29 20:21 Tx date 2024-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$20,000
+16,000 vol $1.25 each |
36,000 | |
| Filed 2024-10-29 20:17 Tx date 2024-10-29 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-26,000 vol |
0 | |
| Filed 2024-10-27 16:00 Tx date 2024-10-24 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,250
+5,000 vol $1.65 each |
26,000 | |
| Filed 2024-10-27 15:59 Tx date 2024-10-24 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$9,200
+5,000 vol $1.84 each |
21,000 | |
| Filed 2024-10-27 15:58 Tx date 2024-10-24 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,250
-5,000 vol $1.65 each |
20,000 | |
| Filed 2024-10-27 15:57 Tx date 2024-10-24 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-9,200
-5,000 vol $1.84 each |
25,000 | |
| Filed 2024-10-27 15:48 Tx date 2024-03-22 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,800
+20,000 vol $1.84 each |
36,000 | |
| Filed 2024-10-27 15:46 Tx date 2024-10-03 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,500
+10,000 vol $1.65 each |
46,000 | |
| Filed 2024-10-26 16:09 Tx date 2024-10-24 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$256,000,000
+16,000 vol $16,000 each |
16,000 | |
| Filed 2024-10-26 16:08 Tx date 2024-10-24 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-100,000
-16,000 vol $6.25 each |
0 | |
| Filed 2024-10-26 16:06 Tx date 2023-07-14 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-64,000 vol |
16,000 | |
| Filed 2024-10-26 16:05 Tx date 2023-07-14 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-24,000 vol |
6,000 | |
| Filed 2024-10-23 21:21 Tx date 2024-10-15 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-96,696
-2,400 vol $40.29 each |
24,000 | |
| Filed 2024-10-18 09:45 Tx date 2024-10-15 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,400 vol |
||
| Filed 2024-10-18 09:45 Tx date 2024-10-15 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,400 vol |
24,000 | |
| Filed 2023-08-09 03:46 Tx date 2023-08-08 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-22,428
-3,600 vol $6.23 each |
26,400 | |
| Filed 2022-08-24 10:37 Tx date 2022-08-24 |
$DRUG
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,000
-10,000 vol $3.00 each |
30,000 | |
| Filed 2021-02-01 17:18 Tx date 2021-01-29 |
$
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
80,000 | ||
| Filed 2021-02-01 17:16 Tx date 2021-01-29 |
$
Bright Minds Biosciences Inc. |
Fryzuk, Jeremy
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
40,000 |